Trial Profile
Phase I single ascending dose trial of SYN 120
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Mar 2014
Price :
$35
*
At a glance
- Drugs Landipirdine (Primary)
- Indications Cognition disorders
- Focus Adverse reactions
- 12 Mar 2014 New trial record